KREATECH Biotechnology B.V. Announces REPLI-g(R) Whole Genome Amplification Technology Supply Agreement With QIAGEN For arrayCGH Labeling Kits
Published: Jun 08, 2006
AMSTERDAM, June 8 /PRNewswire/ -- Kreatech Biotechnology BV (www.kreatech.com) and QIAGEN GmbH a wholly-owned subsidiary of QIAGEN (www.qiagen.com) have signed a supply agreement pursuant to which Kreatech will market QIAGEN's REPLI-g® Whole Genome Amplification (WGA) Kits in combination with their proprietary Universal Linkage System (ULS(TM)) for the life science research marketplace. The coupling of the ULS(TM) technology with REPLI-g® will enable Kreatech to offer researchers the advantages of direct labeling of REPLI-g® amplified genomic DNA with ULS(TM).